Predictive factors of postoperative sleep disturbance after total hip arthroplasty: a retrospective observational study of 759 patients
Objectives Postoperative sleep disturbance (PSD) is a common yet easily overlooked complication that affects early postoperative recovery. The purpose of this study was to identify the predictive factors of PSD.Design Retrospective cross-sectional study.Setting The First Affiliated Hospital of Chong...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e091931.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Objectives Postoperative sleep disturbance (PSD) is a common yet easily overlooked complication that affects early postoperative recovery. The purpose of this study was to identify the predictive factors of PSD.Design Retrospective cross-sectional study.Setting The First Affiliated Hospital of Chongqing Medical University.Participants 759 patients undergoing primary unilateral total hip arthroplasty.Main outcome measures PSD was measured using the Numeric Rating Scale score of 1–10 or the Pittsburgh Sleep Quality Index.Results 759 patients were included in the analysis. The incidence of PSD on postoperative day (POD) 1, POD 7 and POD 30 was 55.3%, 19.6% and 14.6%. Predictive factors included preoperative Visual Analogue Scale (VAS) (OR, 1.201 (95% CI, 1.054 to 1.369), p=0.006), satisfaction with ward environment (OR, 0.816 (95% CI, 0.711 to 0.936), p=0.004), dexmedetomidine (OR, 0.493 (95% CI, 0.263 to 0.925), p=0.028) and VAS on POD 1 (OR, 1.203 (95% CI, 1.052 to 1.382), p=0.008). VAS on POD 7 was associated with PSD on POD 7 (OR, 1.360 (95% CI, 1.103 to 1.678), p=0.004). VAS on POD 30 was associated with PSD on POD 30 (OR, 1.236 (95% CI, 1.021 to 1.495), p=0.029).Conclusions Patients who experience preoperative pain, low satisfaction with ward environment, absence of intraoperative dexmedetomidine use and postoperative pain are at high risk of PSD on POD 1 after total hip arthroplasty. Postoperative pain was associated with PSD on POD 7 and 30.Trial registration number Chinese Clinical Trial Registry (ChiCTR2300078231). |
|---|---|
| ISSN: | 2044-6055 |